title: Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras.
abstract: The continued spread of HIV underscores the need to interrupt transmission. One attractive strategy, in the absence of an effective vaccine, is a topical microbicide, but the need for application around the time of sexual intercourse leads to poor patient compliance. Intravaginal (IVAG) application of CD4 aptamer-siRNA chimeras (CD4-AsiCs) targeting the HIV coreceptor CCR5, gag, and vif protected humanized mice from sexual transmission. In non-dividing cells and tissue, RNAi-mediated gene knockdown lasts for several weeks, providing an opportunity for infrequent dosing not temporally linked to sexual intercourse, when compliance is challenging. Here, we investigate the durability of gene knockdown and viral inhibition, protection afforded by CCR5 or HIV gene knockdown on their own, and effectiveness of CD4-AsiCs formulated in a gel in polarized human cervicovaginal explants and in humanized mice. CD4-AsiC-mediated gene knockdown persisted for several weeks. Cell-specific gene knockdown and protection were comparable in a hydroxyethylcellulose gel formulation. CD4-AsiCs against CCR5 or gag/vif performed as well as a cocktail in humanized mice. Transmission was completely blocked by CCR5 CD4-AsiCs applied 2 days before challenge. Significant, but incomplete, protection also occurred when exposure was delayed for 4 or 6 days. CD4-AsiCs targeting gag/vif provided some protection when administered only after exposure. These data suggest that CD4-AsiCs are a promising approach for developing an HIV microbicide.
authors: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
authors: Lee Adam
authors: LA
authors: Wheeler
authors: Vladimir
authors: V
authors: Vrbanac
authors: Radiana
authors: R
authors: Trifonova
authors: Michael A
authors: MA
authors: Brehm
authors: Adi
authors: A
authors: Gilboa-Geffen
authors: Serah
authors: S
authors: Tanno
authors: Dale L
authors: DL
authors: Greiner
authors: Andrew D
authors: AD
authors: Luster
authors: Andrew M
authors: AM
authors: Tager
authors: Judy
authors: J
authors: Lieberman
mesh_terms: D000818:Animals; D015704:CD4 Antigens / Q000235:genetics*; D005260:Female; D005434:Flow Cytometry; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D034741:RNA, Small Interfering / Q000235:genetics*; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism; D014621:Vagina / Q000378:metabolism
chemical_list: D015704:CD4 Antigens; D034741:RNA, Small Interfering; D019713:Receptors, CCR5
references: Nature. 2002 May 2;417(6884):95-8
references: 11986671
references: Cell Host Microbe. 2009 Jan 22;5(1):84-94
references: 19154990
references: J Exp Med. 2007 Apr 16;204(4):705-14
references: 17389241
references: AIDS Res Hum Retroviruses. 2003 Aug;19(8):699-706
references: 13678472
references: Nucleic Acids Res. 2009 May;37(9):3094-109
references: 19304999
references: J Immunol. 2002 Nov 1;169(9):5196-201
references: 12391237
references: Nat Med. 2002 Jul;8(7):681-6
references: 12042777
references: Nat Rev Drug Discov. 2007 Jun;6(6):443-53
references: 17541417
references: Curr Opin Infect Dis. 2012 Feb;25(1):51-7
references: 22156901
references: N Engl J Med. 1997 Apr 10;336(15):1072-8
references: 9091805
references: Clin Biochem Rev. 2008 Aug;29 Suppl 1:S49-52
references: 18852857
references: J Virol. 2003 Nov;77(21):11531-5
references: 14557638
references: Nature. 2002 Jul 25;418(6896):435-8
references: 12087358
references: Infect Control Hosp Epidemiol. 1997 Mar;18(3):161
references: 9090541
references: Nat Biotechnol. 2009 Sep;27(9):839-49
references: 19701187
references: J Infect Dis. 2010 Sep 1;202(5):739-44
references: 20629537
references: PLoS Med. 2008 Jan 15;5(1):e16
references: 18198941
references: Nature. 2006 Jan 5;439(7072):89-94
references: 16306938
references: Sci Transl Med. 2011 Jan 19;3(66):66ra6
references: 21248316
references: Nat Rev Immunol. 2007 Feb;7(2):118-30
references: 17259968
references: Nat Med. 2003 Mar;9(3):347-51
references: 12579197
references: J Virol. 2003 Jul;77(13):7174-81
references: 12805416
references: Mol Ther. 2013 Jan;21(1):192-200
references: 23164935
references: J Exp Med. 1994 Nov 1;180(5):1817-27
references: 7964463
references: Pharm Res. 1995 Apr;12(4):465-83
references: 7596980
references: Cell. 2008 Aug 22;134(4):577-86
references: 18691745
references: Sci Transl Med. 2012 Mar 14;4(125):125ra30
references: 22422991
references: Nat Biotechnol. 2002 May;20(5):500-5
references: 11981565
references: Curr Opin Infect Dis. 2010 Feb;23(1):26-31
references: 19935418
references: Science. 2004 Oct 15;306(5695):485-7
references: 15486300
references: Nat Rev Microbiol. 2006 Apr;4(4):312-7
references: 16541138
references: AIDS Res Hum Retroviruses. 2005 Oct;21(10):845-53
references: 16225411
references: Sex Transm Dis. 1992 Mar-Apr;19(2):88-91
references: 1595017
references: J Virol. 2002 Sep;76(18):9225-31
references: 12186906
references: Front Biosci. 2006 Jan 01;11:89-112
references: 16146716
references: Nat Biotechnol. 2005 Jun;23(6):709-17
references: 15908939
references: Blood. 2006 Jul 15;108(2):487-92
references: 16410443
references: J Clin Invest. 2011 Jun;121(6):2401-12
references: 21576818
references: PLoS One. 2011;6(6):e20209
references: 21673796
references: Nature. 2010 Mar 11;464(7286):217-23
references: 20220840
references: J Virol. 2009 Jul;83(14):7305-21
references: 19420076
references: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4095-100
references: 17360483
references: J Virol. 2003 May;77(9):5201-8
references: 12692222
references: J Exp Med. 2003 Nov 17;198(10):1551-62
references: 14623909
references: Nat Biotechnol. 2006 Aug;24(8):1005-15
references: 16823371
references: Science. 2010 Sep 3;329(5996):1168-74
references: 20643915
references: Am J Public Health. 2010 Oct;100(10):1867-76
references: 20724682
references: Nucleic Acids Res. 1998 Sep 1;26(17):3915-24
references: 9705498
references: Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
references: 1595015
references: Antiviral Res. 2010 Dec;88 Suppl 1:S3-9
references: 21109065